BDRX
Price
$2.80
Change
-$0.25 (-8.20%)
Updated
Jul 2, 04:29 PM (EDT)
Capitalization
2.24M
Intraday BUY SELL Signals
GPCR
Price
$53.47
Change
+$1.34 (+2.57%)
Updated
Jul 2, 04:59 PM (EDT)
Capitalization
3.7B
35 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BDRX vs GPCR

BDRX vs GPCR Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
BDRX vs. GPCR commentary
Jul 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BDRX is a StrongBuy and GPCR is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 03, 2026
Stock price -- (BDRX: $2.92 vs. GPCR: $49.71)
Brand notoriety: BDRX and GPCR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BDRX: 513% vs. GPCR: 106%
Market capitalization -- BDRX: $2.19M vs. GPCR: $3.8B
BDRX [@Biotechnology] is valued at $2.19M. GPCR’s [@Biotechnology] market capitalization is $3.8B. The market cap for tickers in the [@Biotechnology] industry ranges from $134.02B to $0. The average market capitalization across the [@Biotechnology] industry is $2.14B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BDRX’s FA Score shows that 1 FA rating(s) are green whileGPCR’s FA Score has 1 green FA rating(s).

  • BDRX’s FA Score: 1 green, 4 red.
  • GPCR’s FA Score: 1 green, 4 red.
According to our system of comparison, GPCR is a better buy in the long-term than BDRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BDRX’s TA Score shows that 5 TA indicator(s) are bullish while GPCR’s TA Score has 5 bullish TA indicator(s).

  • BDRX’s TA Score: 5 bullish, 4 bearish.
  • GPCR’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, BDRX is a better buy in the short-term than GPCR.

Price Growth

BDRX (@Biotechnology) experienced а +11.88% price change this week, while GPCR (@Biotechnology) price change was +3.22% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.06%. For the same industry, the average monthly price growth was +9.70%, and the average quarterly price growth was +2017.44%.

Reported Earning Dates

GPCR is expected to report earnings on Aug 06, 2026.

Industries' Descriptions

@Biotechnology (+6.06% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GPCR($3.7B) has a higher market cap than BDRX($2.24M). GPCR YTD gains are higher at: -28.526 vs. BDRX (-74.273). BDRX has higher annual earnings (EBITDA): -6.07M vs. GPCR (-218.24M). BDRX (0) and GPCR (0) have equivalent revenues.
BDRXGPCRBDRX / GPCR
Capitalization2.24M3.7B0%
EBITDA-6.07M-218.24M3%
Gain YTD-74.273-28.526260%
P/E RatioN/AN/A-
Revenue00-
Total CashN/A1.46B-
Total DebtN/A5.79M-
FUNDAMENTALS RATINGS
BDRX: Fundamental Ratings
BDRX
OUTLOOK RATING
1..100
49
VALUATION
overvalued / fair valued / undervalued
1..100
27
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
88
P/E GROWTH RATING
1..100
93
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BDRXGPCR
RSI
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
65%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
87%
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 15 days ago
74%
Bullish Trend 7 days ago
85%
Declines
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend about 1 month ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
BDRX
Daily Signal:
Gain/Loss:
GPCR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HRL24.880.06
+0.24%
Hormel Foods Corp
MNRO17.22N/A
N/A
Monro
NBTB49.59N/A
N/A
NBT Bancorp
LVO6.20N/A
N/A
LiveOne Inc
SOBR0.68N/A
N/A
Sobr Safe Inc